结合疗法用于糖尿病糖尿病患者的病
Daniël H van Raalte1,2,3, Petter Bjornstad4, David Z I Cherney5
1Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, VUMC, Amsterdam, The Netherlands. d.vanraalte@amsterdamumc.nl.
Nature reviews. Nephrology
|April 3, 2024
概括
糖尿病病 (DKD) 影响20-40%的糖尿病患者. 新的药物类别提供了改善的脏结果,组合疗法显示有望阻止疾病的进展.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病病 (DKD) 影响20-40%的糖尿病患者.
- DKD是导致功能衰竭,心血管疾病和死亡的主要原因.
- 现有的干预措施在保持功能方面表现出有限的有效性.
研究的目的:
- 审查目前糖尿病病治疗方法的情况.
- 突出新兴药物类别及其在管理DKD方面的潜力.
- 讨论使用新型组合疗法治疗DKD的未来前景.
主要方法:
- 对DKD目前的药理干预措施的审查.
- 对新药类的新出现的临床前和临床证据的分析.
- 讨论联合治疗策略,以阻止DKD的进展.
主要成果:
- 从历史上看,氨酶系统抑制剂是主要的治疗方法.
- 新的药物类别,如SGLT2抑制剂,矿物质皮质醇对抗剂和内甲素受体对抗剂显示出有前途.
- 葡萄糖类-1受体激动剂正在对脏保护进行研究.
结论:
- 多种新的药物类别正在改善2型糖尿病的脏结果.
- 目前正在探索组合疗法,以阻止DKD的进展.
- 多种脏保护药物的可用性为DKD患者提供了更加乐观的未来.
相关概念视频
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
Diabetes: Management and Pharmacotherapy
277
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
277
Dialysis
307
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
307
Antihypertensive Drugs: Potassium-Sparing Diuretics
534
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
534
Antihypertensive Drugs: Direct Renin Inhibitors
616
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
616


